Ecolab Inc.
NYSE:ECLChemicals - Specialty
+$1.18 today
- Market cap
- $84.33B
- Beta
- 0.91
- P/E (TTM)
- 36.2
- EPS (TTM)
- $7.47
- Dividend yield
- 1.05%
Volume 1.26M
Average 1.65M
ECL Research & Development
Spending on developing new products, technologies, and improvements to existing offerings.
Ecolab Inc.NYSE: ECL
Research & Development · Q2 FY2026 · quarter ended Jun 2026
Research & development remains negative
Q2 FY2026 research & development was $0, compared with $0 a year earlier. Trailing-twelve-month research & development was $0.
Context
- Research & development amounted to 0.0% of revenue in FY2025, down 1.3 pp from a year earlier.
- Research & development increased in 2 of the last 3 fiscal years.
- FY2025 was the lowest annual figure in the 4 fiscal years shown.
What to watch
Whether quarterly research & development holds near $0 or moves back toward the trailing-twelve-month quarterly average of $0.
Sources:Income StatementText generated from reported figures; not investment advice.
Research & Development history
USD · from the income statement
- Latest · FY2025
- 0 USD
- Year-over-year change
- -100.0%
| Period | Period end | Research & Development | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | 0 | -100.0% |
| FY2024 | 2024-12-31 | 207M | +7.8% |
| FY2023 | 2023-12-31 | 192M | +1.1% |
| FY2022 | 2022-12-31 | 190M | +2.2% |
| FY2021 | 2021-12-31 | 186M | — |
Research & Development vs competitors
How ECL compares with its peers on the latest reported figures
- Peers report in different currencies, so research & development is compared through growth and share of revenue rather than absolute size.
- Its year-over-year change of -100.0% is the 3rd highest of 5, against a peer median of -50.4%.
- Research & development amounts to 0.0% of revenue for ECL, versus a peer median of 0.0%.
| Company | Period | LTM | YoY | 3-year CAGR | % of revenue |
|---|---|---|---|---|---|
| LTM Jul 2026 | $276M USD | +4.9% | +7.0% | 4.8% | |
| LTM Sep 2026 | $117M USD | -0.8% | -5.6% | 1.6% | |
| LTM Jun 2026 | $0 USD | -100.0% | — | 0.0% | |
| LTM Sep 2026 | $0 USD | — | — | 0.0% | |
| LTM Aug 2026 | $0 USD | -100.0% | — | 0.0% | |
| LTM Jun 2026 | $0 USD | — | — | 0.0% | |
| LTM Jun 2026 | CA$0 CAD | — | — | 0.0% | |
| FY2025 | $0 USD | -100.0% | — | 0.0% | |
| LTM Sep 2026 | $0 USD | — | — | 0.0% | |
| LTM Jun 2026 | $0 USD | — | — | 0.0% | |
| Peer median (excluding ECL) | — | -50.4% | +0.7% | 0.0% | |
Competitors are the stored peer set for ECL. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Income Statement
Metric | FY2021 Dec 2021 | FY2022 Dec 2022 | FY2023 Dec 2023 | FY2024 Dec 2024 | FY2025 Dec 2025 |
|---|---|---|---|---|---|
| Revenue | 12.73B | 14.19B | 15.32B | 15.74B | 16.08B |
| Cost of Revenue | 7.51B | 8.77B | 9.14B | 8.9B | 8.92B |
| Gross Profit | 5.22B | 5.42B | 6.18B | 6.84B | 7.16B |
| Gross Margin | 41.0% | 38.2% | 40.3% | 43.5% | 44.5% |
| Research & Development | 186M | 190M | 192M | 207M | 0 |
| Selling, General & Admin | 3.35B | 3.62B | 3.82B | 4.02B | 4.26B |
| Operating Expenses | 3.54B | 3.81B | 4.02B | 4.23B | 4.25B |
| Depreciation & Amortization | 843.1M | 938.7M | 923.6M | 935.4M | 672.6M |
| EBITDA | 2.47B | 2.55B | 3.03B | 3.85B | 3.46B |
| EBITDA Margin | 19.4% | 17.9% | 19.8% | 24.4% | 21.5% |
| Operating Income | 1.68B | 1.61B | 2.16B | 2.61B | 2.91B |
| Operating Margin | 13.2% | 11.3% | 14.1% | 16.6% | 18.1% |
| Interest Income | 12.3M | 8.5M | 52.2M | 57.8M | 0 |
| Interest Expense | 216.2M | 263.7M | 354.7M | 338.4M | 241.1M |
| Other Income / Expenses | (270.3M) | (266.1M) | (405.2M) | (41.2M) | (364.7M) |
| Income Before Tax | 1.41B | 1.34B | 1.76B | 2.57B | 2.55B |
| Pre-Tax Margin | 11.1% | 9.5% | 11.5% | 16.3% | 15.8% |
| Income Tax Expense | 270.2M | 234.5M | 362.5M | 439.3M | 454.6M |
| Net Income | 1.13B | 1.09B | 1.37B | 2.11B | 2.08B |
| Net Margin | 8.9% | 7.7% | 9.0% | 13.4% | 12.9% |
| EPS (Basic) | 3.95 | 3.83 | 4.82 | 7.43 | 7.33 |
| EPS (Diluted) | 3.91 | 3.81 | 4.79 | 7.37 | 7.28 |
| Weighted Avg Shares | 286.3M | 285.2M | 285M | 284.3M | 283.3M |
| Weighted Avg Shares (Diluted) | 289.1M | 286.6M | 286.5M | 286.6M | 285.2M |
Ecolab Inc.
NYSE:ECL
Intrinsic Alpha fair value
Locked
Current Price
$300.68
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.